The Rising Cost of GLP-1s and What Employers Can Do:

GLP-1 drug spending is rising, with obesity treatment costs tripling in just a few years. Fresh Tri gives employers a cost-effective way to support weight and metabolic health based on scientific research and without relying solely on prescriptions.

Employers across the country are feeling the pressure: healthcare costs are rising, and GLP-1 medications, initially developed for diabetes but now widely prescribed for obesity, are at the center of it.

The surge in demand for these drugs has transformed the landscape of chronic condition spending. But is medication the only solution? And more importantly, is it sustainable?

Glp-1s Are A Cost Driver Few Saw Coming

In 2020, GLP-1s accounted for just over $5 per member per month (PMPM) in healthcare spending. By 2023, that number had more than tripled, hitting $18.27 PMPM. This category now surpasses some surgical procedures in cost and continues to rise.

One of the most significant shifts is that more GLP-1 spending is now going toward patients with obesity but no diabetes diagnosis. In just three years, this spending jumped from 4% to 16.5% of all GLP-1-related costs. This change signals a major transition from treating disease to trying to prevent it but at a steep price.

Medication Alone Can’t Fix the Problem

Obesity and other chronic conditions are rooted in complex behavioral and environmental patterns. GLP-1s can help, but they don’t solve the underlying causes. Employers know this. They’re looking for ways to manage risk without breaking the bank or placing too much weight on pharmacological solutions alone.

That’s where Fresh Tri offers a different path.

A New Approach to Weight and Metabolic Health

Fresh Tri gives employers a new way to support employees living with or at risk for chronic conditions, which is backed by neuroscience research and doesn’t rely on medications.

At the core of this approach is the Iterative Mindset Method™: a behavioral model that helps people adopt and maintain healthier habits through consistent practice and personalization.

Instead of chasing perfection or relying on unsustainable willpower, Fresh Tri guides users to:

Reduce stress on the brain’s motivation center (the habenula)
Avoid “quitting cycles” that undermine lasting progress
Build healthier habits through minor, self-directed tweaks over time

As a result, more individuals take control over their lives, lower long-term costs, and adopt a preventive model that complements medical treatment when needed.

What Employers Can Do Now

As GLP-1s continue to drive up costs, employers need smarter strategies. That means:

Identifying populations at risk for long-term medication use
Offering non-pharmacological interventions that are backed by science and are scalable
Partnering with programs that support both physical and mental health holistically

Fresh Tri was built for this moment, where rising demand, budget limits, and employee health needs intersect. Our model supports the whole person and helps employers take meaningful action today to reduce future risk.

The Rising Cost of GLP-1s and What Employers Can Do:

Glp-1s Are A Cost Driver Few Saw Coming

Medication Alone Can’t Fix the Problem

A New Approach to Weight and Metabolic Health

What Employers Can Do Now

Contact Us

Why Fresh Tri

About

Features